Oracle’s updated pricing framework now reflects a fair value estimate of US$241.97, compared with the previous US$248.15 level. This adjustment lines up with a more mixed analyst narrative, as stronger interest in Oracle Cloud Infrastructure and large AI contracts is being balanced against concerns about funding needs, capital expenditure and potential pressure on earnings quality. As you read on, you will see how these moving pieces are shaping the evolving Oracle story and what to watch as new research arrives.
What Wall Street Has Been Saying 🐂 Bullish Takeaways
Several firms, including TD Cowen, Cantor Fitzgerald, Oppenheimer and Evercore ISI, highlight Oracle as a key AI and cloud beneficiary, pointing to interest in Oracle Cloud Infrastructure, large AI contracts and broader database and applications demand.
Wedbush, BMO Capital and DA Davidson point to Oracle’s recent Q4 report as supportive for the long term, citing solid top and bottom line results, strong remaining performance obligations of US$638b and confidence from management in long term targets.
Barclays and Citi describe recent Q4 results as mixed but see more positives than negatives. Barclays emphasizes ongoing AI demand evidenced by another large remaining performance obligation figure, and Citi references financial discipline.
Mizuho views the expanded US Department of Veterans Affairs Oracle Health contract, with a ceiling near US$27b, as a positive that increases Oracle Health’s long term revenue opportunity.
🐻 Bearish Takeaways
JPMorgan and Bernstein flag Oracle’s capital needs and higher capital expenditure plans, including the US$40b capital raise in FY27, as a source of concern for some investors who question the impact on earnings quality and dilution.
Citi and RBC Capital highlight pressure on gross margins and a cloud revenue outcome that was below consensus in Q4. Together with elevated capital spending, this shapes a more cautious stance on Oracle’s near term earnings outlook.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!
NYSE:ORCL 1-Year Stock Price Chart
We’ve flagged 2 risks for Oracle. See which could impact your investment.
What’s in the News
OpenAI has agreed to purchase about US$300b in computing capacity from Oracle starting in 2027, and commentary points out that nearly half of Oracle’s contracted revenue is tied to this partner, which raises concentration risk if OpenAI faces difficulties.
Oracle secured a US$17b expansion of its U.S. Department of Veterans Affairs Oracle Health electronic health record contract, taking the total potential value to about US$27b with options that could extend deployment through May 2031.
Reports on AI infrastructure spending state that Oracle plans to raise about US$40b through debt and equity to support its AI buildout, alongside a cited debt level of about 2.5 times sales and a recent credit rating downgrade linked to these commitments.
Oracle is reportedly cutting roughly 3,000 jobs in India as part of broader workforce reductions tied to funding requirements for AI data centers, while company commentary points to strong demand for Oracle Cloud Infrastructure capacity.
Story Continues
How This Changes the Fair Value For Oracle
Fair value estimate for Oracle has shifted from US$248.15 to US$241.97.
Revenue growth assumption is broadly stable, moving from 39.23% to 39.32%.
Net profit margin estimate has been adjusted from 22.92% to 23.23%.
Future P/E multiple has been revised from 23.68x to 22.58x.
Discount rate has edged down from 9.86% to 9.60%.
Never Miss an Update: Follow The Narrative
Narratives link Oracle’s business story to a structured financial forecast and fair value framework. They update as new contracts, funding plans, and analyst assumptions are added.
Head over to the Simply Wall St Community and follow the Narrative on Oracle to stay up to date on:
How demand for AI workloads and Oracle Cloud Infrastructure is shaping long multi year contracts and remaining performance obligations.
The role of Oracle’s AI integrated database, cloud migration offerings, and healthcare AI products in attracting large enterprise customers.
Key risks around concentrated AI customers, very high planned CapEx, competitive pressure from other hyperscalers, and the possibility of underused data center capacity.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ORCL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com